Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP148892.RABKSh9HBNsNUUdgXV75SSIZJy_6qEz2yz7--CvNfhjJs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP148892.RABKSh9HBNsNUUdgXV75SSIZJy_6qEz2yz7--CvNfhjJs130_assertion type Assertion NP148892.RABKSh9HBNsNUUdgXV75SSIZJy_6qEz2yz7--CvNfhjJs130_head.
- NP148892.RABKSh9HBNsNUUdgXV75SSIZJy_6qEz2yz7--CvNfhjJs130_assertion description "[We screened for the most common LRRK 2 mutation in a series of patients with Parkinson's Disease, Alzheimer's disease, Progressive Supranuclear Palsy, Multiple System Atrophy and frontotemporal dementia, as well as in neurologically normal controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP148892.RABKSh9HBNsNUUdgXV75SSIZJy_6qEz2yz7--CvNfhjJs130_provenance.
- NP148892.RABKSh9HBNsNUUdgXV75SSIZJy_6qEz2yz7--CvNfhjJs130_assertion evidence source_evidence_literature NP148892.RABKSh9HBNsNUUdgXV75SSIZJy_6qEz2yz7--CvNfhjJs130_provenance.
- NP148892.RABKSh9HBNsNUUdgXV75SSIZJy_6qEz2yz7--CvNfhjJs130_assertion SIO_000772 16102903 NP148892.RABKSh9HBNsNUUdgXV75SSIZJy_6qEz2yz7--CvNfhjJs130_provenance.
- NP148892.RABKSh9HBNsNUUdgXV75SSIZJy_6qEz2yz7--CvNfhjJs130_assertion wasDerivedFrom lhgdn-20090331 NP148892.RABKSh9HBNsNUUdgXV75SSIZJy_6qEz2yz7--CvNfhjJs130_provenance.
- NP148892.RABKSh9HBNsNUUdgXV75SSIZJy_6qEz2yz7--CvNfhjJs130_assertion wasGeneratedBy ECO_0000203 NP148892.RABKSh9HBNsNUUdgXV75SSIZJy_6qEz2yz7--CvNfhjJs130_provenance.